The provisions directly concern people who may be referred to the Drug Court, the courts that can make specified referrals, the Drug Court and its registrar, prosecutors, treatment providers, health bodies, and the people or organisations supplying facilities.

For a person considered under s 4, the prescribed residence area must be one of the 33 local government areas in Schedule 1. The person must be at least 18, and the criminal proceedings must not be within the Children’s Court’s jurisdiction to hear and determine. The person must also not have a mental health impairment or cognitive impairment that could prevent or restrict active program participation. These are prescribed criteria under s 5(1)(e) of the Act; the regulation does not say that satisfying them alone guarantees referral or acceptance.

For a convicted offender considered under s 5, the relevant area is one of the 34 local government areas in Schedule 2, and the person must be at least 18. The person may qualify geographically by being able to reside in a listed area, not only by already residing there. The proceedings must be outside the Children’s Court’s jurisdiction, and the person must be male. Section 5 does not reproduce a mental-health or cognitive-impairment criterion.

The District Court and Local Court are prescribed for referrals during proceedings under s 6. For eligible convicted offenders, s 9 also prescribes those courts, the Drug Court for specified sentences, and the Court of Criminal Appeal for specified appeals. Section 11 prescribes staff acting for named Local Health Districts, NSW Health Pathology’s Drug Toxicology Unit, and organisations providing treatment connected with a person’s program as potential information providers.

Section 7 sets four guidelines for the availability and allocation of facilities. The provider must be willing to supervise and control the person’s program participation; facilities must be reasonably likely to be available when needed; the Drug Court must have received a suitable treatment plan; and, in the Court’s opinion, the facilities must be suitable for delivering treatment in accordance with that plan. These are prescribed guidelines linked to ss 7A and 7B of the Act. The text does not prescribe a particular provider, treatment type, service level, or method for resolving a shortage of facilities.

Section 8 modifies the operation of s 265(1) and (2) of the Criminal Procedure Act 1986 in proceedings before the Drug Court under ss 7A, 7B or 7C of the Act. The obligations of the Drug Court and prosecutor under those subsections are suspended in relation to a charged person if that person consents to suspension. The suspension ends if the person withdraws consent, consents to being dealt with under s 7D, is referred back to the referring court under s 7D, or is dealt with under s 7E. The regulation does not reproduce the content of s 265, so the precise obligations affected must be checked against that Act.

Section 11 specifies who may provide information under s 31 of the Act and how information is delivered to the registrar. It may be given in person, by post or delivery, or electronically. Information given other than in writing must be confirmed in writing within 24 hours unless the registrar indicates otherwise.

Sections 13 and 14 address fees and referral-back orders. A fee applicable in District or Local Court criminal proceedings may also be charged in corresponding Drug Court proceedings; the Drug Court may postpone, waive or remit it, with or without conditions. The registrar may exercise that fee function. A referral-back order may be made in the person’s absence.

The supplied regulation does not create a standalone offence, specify a fine, or prescribe a term of imprisonment. It should not be read as establishing penalties for failing to meet an eligibility criterion, a facility guideline, or an information procedure. The relevant provisions instead regulate access, court procedure, information flow, and fees within the Drug Court framework.

The most direct financial provision is s 13. It allows a fee that may be charged in criminal proceedings before the District Court or Local Court to also be charged in corresponding Drug Court proceedings where the Drug Court is exercising that court’s criminal jurisdiction. The Drug Court may postpone, waive or remit such a fee, unconditionally or subject to conditions. Section 13(3) allows the registrar to exercise that function. The text does not state the amounts of fees, identify which proceedings attract a fee, or set criteria for deciding whether to postpone, waive or remit one.

Section 8 has procedural consequences rather than a stated penalty. If a charged person consents, specified obligations of the Drug Court and prosecutor are suspended for a defined period. The suspension ends on one of the events listed in s 8(3). Because the regulation does not reproduce Criminal Procedure Act s 265, the source supplied does not establish the practical scope of the suspended obligations.

Section 14 permits the Drug Court to make a referral-back order in the person’s absence. Section 10 permits the registrar to notify a court of such an order. These provisions establish a mechanism for communicating and making an order, but the regulation does not specify a sanction for non-compliance with the order. Any further consequence would require examination of the Act and other applicable sources, which are not reproduced here.

The regulation is subordinate legislation made by reference to the Drug Court Act 1998. Its provisions repeatedly identify the Act sections under which criteria or procedures are prescribed: ss 4 and 5 refer to Act ss 5 and 5A; s 6 to ss 6 and 7; s 7 to ss 7A and 7B; s 8 to s 18; s 9 to s 18B; and ss 10 to 14 to the Act provisions identified in each heading. The regulation supplies selected details; it does not replace those Act provisions.

Section 3 says that the Act and the Interpretation Act 1987 contain definitions and other provisions affecting interpretation and application of the regulation. Section 4 adopts the meanings of “cognitive impairment” and “mental health impairment” in the Mental Health and Cognitive Impairment Forensic Provisions Act 2020. The supplied text does not reproduce those definitions, so their precise scope cannot be set out from this material alone.

Section 8 modifies the application of Criminal Procedure Act 1986 s 265(1) and (2) for the specified Drug Court proceedings, but only where the charged person consents to suspension. The modification is expressly bounded by s 8(3), which lists the events that end the suspension.

The regulation also identifies the Subordinate Legislation Act 1989 as the mechanism by which the 2020 regulation is repealed on 1 September 2026. The Drug Court regulation’s notes describe that repeal as occurring under s 10(2). These cross-references show which other laws are relevant, but do not provide enough text to explain all their operation or resolve any inconsistency between them.

The supplied text is titled Drug Court Regulation 2026. Section 2 states that it commences on 1 September 2026. It also states that the Drug Court Regulation 2020 is repealed on that date under s 10(2) of the Subordinate Legislation Act 1989. The material therefore describes a replacement instrument with a specified commencement date, not a series of amendments made to the 2020 regulation.

Section 15 contains a savings provision. An act, matter or thing that had effect under the 2020 regulation immediately before its repeal continues to have effect under the 2026 regulation. This provides continuity for matters already operating under the earlier regulation, subject to the wording of the savings clause. The text does not list the saved matters, state how individual transitional situations are to be identified, or specify an exception to the continuation rule.

No amendment table, amendment notes, explanatory statement, or commencement proclamation is included in the material. Accordingly, the text does not establish whether the 2026 regulation was subsequently amended, what provisions may have changed compared with the 2020 regulation, or the policy reasons for choosing the new criteria and procedures. It also does not provide a version history for the schedules or the relevant Act provisions.

For a comparison with the predecessor, the operative provisions of the Drug Court Regulation 2020 would need to be examined alongside this text. The current material supports a limited chronology: a 2020 regulation is identified as the predecessor; the 2026 regulation is scheduled to commence on 1 September 2026; and the predecessor is stated to be repealed on the same date, with the specified savings effect.

The supplied regulation contains no references to decided cases, pending proceedings, judicial interpretation, or litigation concerning its provisions. It therefore does not establish whether a court has considered the meaning of “usual place of residence”, “could prevent or restrict”, “reasonably likely”, “suitable treatment plan”, or any other phrase in the regulation.

Nor does the text establish that no litigation exists. A regulation’s text is not a litigation database, and absence of case citations in the instrument cannot demonstrate absence of relevant cases. The supplied material also does not include judgments, tribunal decisions, practice directions, court statistics, or commentary that could support a litigation-history account.

The provisions most likely to require factual application include the different residence tests in ss 4 and 5, the functional participation criterion in s 4, and the Court’s opinion about facility suitability under s 7(d). Section 8 may also raise questions about the scope and timing of a consent-based suspension, but the regulation does not reproduce the underlying Criminal Procedure Act obligations or provide any case interpretation.

A source-grounded account can therefore say only that no litigation history is identified in the supplied text. It cannot responsibly name cases, describe judicial trends, or state how courts have resolved these issues. Any assessment of litigation would require checking relevant judgments and the current versions of the cross-referenced Acts. That limitation is particularly important because the regulation is scheduled to commence on 1 September 2026, and the supplied text does not show whether any decisions will be made before or after commencement.

The two eligibility schedules should not be treated as one combined geographic list. Schedule 1 applies to eligible persons under s 4, while Schedule 2 applies to eligible convicted offenders under s 5. Some areas appear in both schedules, but not all. For example, Schedule 1 includes Dubbo Regional, City of Cessnock, City of Lake Macquarie, City of Maitland and Port Stephens, which are not listed in Schedule 2. Schedule 2 includes City of Blue Mountains, Camden, Central Coast, Hornsby, Ku-ring-gai, Northern Beaches, Sutherland Shire and Wollongong, which are not listed in Schedule 1. The applicable schedule depends on the statutory pathway.

The residence tests also differ. Section 4 requires the person’s usual place of residence to be in a Schedule 1 area. Section 5 permits either usual residence in a Schedule 2 area or an ability to reside there. The regulation does not define “usual place of residence” or “able to reside”.

The eligibility criteria are not otherwise identical. Section 4 includes the mental health and cognitive impairment participation criterion; s 5 expressly requires a convicted offender to be male and does not repeat that impairment criterion. Both provisions require age 18 or older and exclude proceedings within the Children’s Court’s jurisdiction.

Referral does not itself appear to guarantee admission. Section 7 makes facilities dependent on willingness, likely availability, receipt of a suitable plan and the Drug Court’s suitability opinion. Section 8’s suspension requires the person’s consent, and ends on specified events. The supplied text does not explain how consent is recorded or withdrawn. Finally, referral-back orders may be made in the person’s absence under s 14, so that procedural possibility should not be confused with the separate registrar notification function in s 10.

The regulation does not set out a single compliance checklist for all participants. Its requirements attach to different people and bodies at different stages. A useful reading is to identify the relevant statutory pathway first, then map the regulation’s criteria and procedural requirements to the actor involved. This is an explanation of the text, not a determination that any particular person meets a criterion or has fulfilled a legal obligation.

For eligibility under s 4, the material to assess against the regulation includes the person’s usual place of residence, age, the court jurisdiction applicable to the proceedings, and whether a mental health or cognitive impairment could prevent or restrict active participation. The applicable geographic list is Schedule 1. For the convicted-offender pathway under s 5, the relevant considerations include age, whether the person is male, whether the proceedings are outside the Children’s Court’s jurisdiction, and either usual residence in a Schedule 2 area or ability to reside there. The regulation does not prescribe a form of proof for these matters.

For facility allocation, s 7 identifies the considerations: provider willingness to supervise and control participation, likely availability when needed, receipt by the Drug Court of a suitable treatment plan, and the Court’s view of suitability. The regulation does not state who prepares the plan or prescribe its contents.

Where information is provided to the registrar under s 31, s 11 permits in-person, postal, delivery or electronic transmission. Information given otherwise than in writing must be confirmed in writing within 24 hours unless the registrar indicates otherwise. A referral under ss 6 or 9 is made by notifying the registrar. The source does not specify notification forms or operational channels beyond that description. This is general legal information, not legal advice; Zoe can make mistakes, and a qualified Australian lawyer should check it before it is acted on, relied on, or used.